Clinical Trial: Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2
Brief Summary: The investigators propose to conduct a comparative pilot cognitive and psychiatric profiles of 10 patients Facio-Scapulo-Humeral Dystrophy (= FHSD) type 1 and 10 patients with type 2 FSHD study. For this, the investigators relied on observational components: FSHD2 patients appear more often present with psychiatric comorbidities and seem to have lower cognitive performance compared to FSHD1 patients. This was confirmed by a preliminary study on a small sample population of patients. It seems to exist mainly executive dysfunction associated with attention disorders in patients FSHD2. Moreover, their performance in IQ tests would be low in relation to their socio-educational and compared with patients FSHD1 level.
Detailed Summary:
Sponsor: Centre Hospitalier Universitaire de Nice
Current Primary Outcome:
- Montgomery and Asberg Depression Rating Scale [ Time Frame: One time at the inclusion ]
- Hamilton Depression Rating Scale [ Time Frame: One time at the inclusion ]
- Hamilton Anxiety Rating Scale [ Time Frame: One time at the inclusion ]
- Quick inventory of depressive symptomatology Self report [ Time Frame: One time at the inclusion ]
- Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form [ Time Frame: One time at the inclusion ]
- Mini Mental Status Evaluation [ Time Frame: One time at the inclusion ]
- Wechsler Adult Intelligence Scale [ Time Frame: One time at the inclusion ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Centre Hospitalier Universitaire de Nice
Dates:
Date Received: December 10, 2013
Date Started: January 2014
Date Completion:
Last Updated: January 9, 2014
Last Verified: December 2013
